Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.

Biotechnology

Immuneering

Ben Zeskind

Jan De Jong

Danielle Flannery

Chris Walker

Edward Slezinger

Anastasia Gutierrez

Amy Axel

Melissa Martin

Dominique Hinds

Harold E.B. Brakewood

Max Peterson

Alex Peterson

Pedram Banishahabadi

Leah Neufeld

Michael Bookman

Mallory Morales

Brett Hall

The Scientific Team at Immuneering conducts advanced research and development to support the company's innovative drug discovery pipeline. This multidisciplinary group focuses on translating bioinformatics insights into actionable therapeutic strategies, overseeing clinical trials, and ensuring the efficient progression of drug candidates targeting challenging aspects of diseases, including cancer cachexia and metastasis.

Scientific Team

Scientific Research Team

Leadership Team

Scientific Team

About

Team members

Other teams at Immuneering

Scientific Research Team

Leadership Team